Other Species / Isoforms
  BID (human)      LTP 

LTP (Low Throughput Papers) : The number of records in which this modification site was determined using methods other than discovery mass spectrometry.

  HTP 

HTP (High Throughput Papers): The number of records in which this modification site was assigned using ONLY proteomic discovery mass spectrometry.

 
-
gap
0 1
BID (human) gap -
BID iso2 (human) _____MCsGAGVMMA S3-p
BID (mouse) gap -
BID (rat) gap -
-
gap
0 1
BID (human) gap -
BID iso2 (human) RSTVRILsPLGHCEP S28-p
BID (mouse) gap -
BID (rat) gap -
Y54-p
LAPQWEGyDELQtDG
0 247
BID (human) LAPQWEGyDELQtDG Y54-p
BID iso2 (human) LAPQWEGYDELQTDG Y100
BID (mouse) AYWEADLEDELQtDG E53
BID (rat) VYLEGDREDELQTDG E54
T59-p
EGyDELQtDGNRsSH
Upstream
3 2
Kinase, in vitro:
  • JNK1 (human)
  • JNK2 (human)
  • JNK3 (human)
view more >
Putative in vivo kinases:
  • JNK1 (human)
  • JNK2 (human)
Regulatory protein:
  • ALDH1L1 (human)
Treatment
  • camptothecin
  • TRAIL
BID (human) EGyDELQtDGNRsSH T59-p
BID iso2 (human) EGYDELQTDGNRSSH T105
BID (mouse) DLEDELQtDGsQAsR T58-p
BID (rat) DREDELQTDGSRASR T59
N62
DELQtDGNRsSHsRL
3 0
BID (human) DELQtDGNRsSHsRL N62
BID iso2 (human) DELQTDGNRSSHSRL N108
BID (mouse) DELQtDGsQAsRsFN S61-p
BID (rat) DELQTDGSRASRSFY S62
S64-p
LQtDGNRsSHsRLGR
Upstream
Downstream
1 0
Effects on Biological Processes:
  • apoptosis, inhibited
  • cell differentiation, induced
Putative in vivo kinases:
  • CK1A (human)
Treatment
  • siRNA
BID (human) LQtDGNRsSHsRLGR S64-p
BID iso2 (human) LQTDGNRSSHSRLGR S110
BID (mouse) LQtDGsQAsRsFNQG A63
BID (rat) LQTDGSRASRSFYHG A64
S65
QtDGNRsSHsRLGRI
3 0
BID (human) QtDGNRsSHsRLGRI S65
BID iso2 (human) QTDGNRSSHSRLGRI S111
BID (mouse) QtDGsQAsRsFNQGR S64-p
BID (rat) QTDGSRASRSFYHGR S65
S67-p
DGNRsSHsRLGRIEA
Upstream
Downstream
2 5
Effects on Biological Processes:
  • apoptosis, induced
  • apoptosis, inhibited
  • cell cycle regulation
  • cell differentiation, induced
Putative in vivo kinases:
  • CK1A (human)
Treatment
  • nocodazole
  • siRNA
BID (human) DGNRsSHsRLGRIEA S67-p
BID iso2 (human) DGNRSSHSRLGRIEA S113
BID (mouse) DGsQAsRsFNQGRIE S66-p
BID (rat) DGSRASRSFYHGRIE S67
S76-p
LGRIEADsEsQEDII
Upstream
1 0
Treatment
  • camptothecin
  • TRAIL
BID (human) LGRIEADsEsQEDII S76-p
BID iso2 (human) LGRIEADSESQEDII S122
BID (mouse) QGRIEPDSEsQEEII S76
BID (rat) HGRIEPDSEsQDEVI S77
S78-p
RIEADsEsQEDIIRN
Upstream
6 6
Treatment
  • KU-55933
BID (human) RIEADsEsQEDIIRN S78-p
BID iso2 (human) RIEADSESQEDIIRN S124
BID (mouse) RIEPDSEsQEEIIHN S78-p
BID (rat) RIEPDSEsQDEVIHN S79-p
R123
TSRSEEDRNRDLATA
0 1
BID (human) TSRSEEDRNRDLATA R123
BID iso2 (human) TSRSEEDRNRDLATA R169
BID (mouse) GSLSEEDkRNCLAkA K123-ub
BID (rat) GSLSEEDKRNCLAKA K124
R123
TSRSEEDRNRDLATA
0 1
BID (human) TSRSEEDRNRDLATA R123
BID iso2 (human) TSRSEEDRNRDLATA R169
BID (mouse) GSLSEEDKRNCLAkA K123
BID (rat) GSLSEEDkRNCLAKA K124-ac
T129
DRNRDLATALEQLLQ
0 1
BID (human) DRNRDLATALEQLLQ T129
BID iso2 (human) DRNRDLATALEQLLQ T175
BID (mouse) DkRNCLAkALDEVkT K129-ub
BID (rat) DkRNCLAKALDEVKT K130
L135
ATALEQLLQAYPRDM
0 1
BID (human) ATALEQLLQAYPRDM L135
BID iso2 (human) ATALEQLLQAYPRDM L181
BID (mouse) AkALDEVkTAFPRDM K135-ub
BID (rat) AKALDEVKTSFPRDM K136
K158-ub
LALLLAKkVASHTPS
0 32
BID (human) LALLLAKkVASHTPS K158-ub
BID iso2 (human) LALLLAKKVASHTPS K204
BID (mouse) MTMLLAKKVASHAPS K158
BID (rat) MTMLLAKKVASHAPS K159